INFUSIONSSET

Patent europeic · EP1984044 · En vigur

Inscripziun en il register

Numer da publicaziun
EP1984044
Numer da la dumonda
EP07717137
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
31-01-2007
Publitgà
29-10-2008
Concedì
23-02-2011
La protecziun finescha il pli tard
30-01-2027
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
A61M 5/158 (2006.01)
A61M 25/06 (2006.01)
Prioritad
US 771139 P 07.02.2006
US 417503 03.05.2006
US 417613 03.05.2006
US 417660 03.05.2006
Dumonda PCT
PCT/US2007/002535 31.01.2007
Publicaziun PCT
WO2007/092210 16.08.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-02-2026

    Transferì

    Owner
    Ypsomed AG, Brunnmattstrasse 6, 3401 Burgdorf → mylife Diabetes Care AG, Lyssachstrasse 40, 3400 Burgdorf
    Representative
    IP Abteilung -mylife Diabetes Care AG, Lyssachstrasse 40, 3400 Burgdorf

    Published in Swissreg on 25.02.2026

  2. 01-02-2026

    Midada

    Published in Swissreg on 01.02.2026

  3. 01-02-2025

    Midada

    Published in Swissreg on 01.02.2025

  4. 14-10-2024

    Transferì

    Owner
    TecPharma Licensing AG, Brunnmattstrasse 6, 3401 Burgdorf → Ypsomed AG, Brunnmattstrasse 6, 3401 Burgdorf

    Published in Swissreg on 14.10.2024

  5. 26-09-2024

    Represchentant stritgà

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25 (allontanà)

    Published in Swissreg on 26.09.2024

  6. 26-09-2024

    Transferì

    Owner
    ICU Medical, Inc., 951 Calle Amanecer, San Clemente, CA 92673, USA → TecPharma Licensing AG, Brunnmattstrasse 6, 3401 Burgdorf

    Published in Swissreg on 26.09.2024

  7. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  8. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

2 endataziuns pli veglias
  1. 02-04-2011

    Represchentant inscrit

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 02.04.2011

  2. 23-02-2011

    Concedì

    Published in Swissreg on 23.02.2011

Partidas

Represchentant

IP Abteilung -mylife Diabetes Care AG

3400 Burgdorf

Inventur

FANGROW, Thomas, F., Jr.

Mission Viejo, CA 92691, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.